MVP 17.3% 47.5¢ medical developments international limited

Ann: Appendix 4C & Quarterly Activity Report - 31 March 2024, page-2

  1. 500 Posts.
    lightbulb Created with Sketch. 69
    I dont know what these guys will say today .. notwithstanding

    They have no money left, despite the cost cutting, program stagnation, innovation back pedal ... etc
    The foray into a direct selling model in Europe looks like a very expensive dud, they are now talking licensing deals, just like 5 years ago
    The costs associated with the US expansion are to much for the co to handle, so they are forced to stop, and do what, they dont say.
    I have owned this stock a couple of times am presently pleasingly out.... I feel the only real hope for this outstanding product ( I have used it and its fantastic) was the USA, I have been sitting on the side lines for some positive news re the US, I just could not believe that they took so long to realise that they would have to stump up to get to the usa. That cant be a recent realization.... Really.

    Disappointed or what, I really wanted to see new positive US news so that I could buy in again.

    Management has a lot to answer for as they have been taking the big wages.
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
47.5¢
Change
0.070(17.3%)
Mkt cap ! $40.99M
Open High Low Value Volume
41.0¢ 48.5¢ 40.5¢ $100.2K 226.8K

Buyers (Bids)

No. Vol. Price($)
1 2200 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
48.0¢ 3000 1
View Market Depth
Last trade - 16.10pm 29/05/2024 (20 minute delay) ?
Last
47.0¢
  Change
0.070 ( 13.3 %)
Open High Low Volume
42.0¢ 48.0¢ 42.0¢ 22835
Last updated 15.58pm 29/05/2024 ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.